Nanoparticles exhibiting self-regulating temperature as innovative agents for Magnetic Fluid Hyperthermia

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Magnetic fluid hyperthermia (MFH) is a promising localized cancer therapy.
• Developing biocompatible nanomaterials with controlled heating is crucial for MFH efficacy.
• Current methods require precise temperature monitoring to avoid healthy tissue damage.

Purpose of the Study:

• To evaluate the M48 nanomaterial as an efficient mediator for magnetic fluid hyperthermia.
• To investigate the potential of M48 as a temperature-sensitive MRI contrast agent.
• To assess the biocompatibility and in vivo efficacy of M48 for breast cancer treatment.

Main Methods:

• Synthesis and characterization of M48 iron oxide-based nanomaterial with citrate-glucose coating.
• In vitro and in vivo studies on breast cancer cells and tumors.
• Assessment of self-regulating hyperthermia up to the Curie temperature.
• Evaluation of magnetic resonance imaging (MRI) relaxivity changes with temperature.

Main Results:

• M48 exhibits self-regulating temperature control due to a ferromagnetic-to-paramagnetic phase transition at its Curie temperature.
• High biocompatibility of M48 was confirmed for in vivo applications.
• Effective in vitro and in vivo hyperthermia was demonstrated in breast cancer models.
• M48 showed a temperature-dependent switch in T2 relaxivity, enabling MRI contrast changes.

Conclusions:

• M48 is a promising nanomaterial for tunable and precise magnetic fluid hyperthermia in oncology.
• The temperature-sensitive MRI contrast capability of M48 allows for real-time monitoring of therapeutic temperature.
• This dual functionality offers a safer and more effective approach to cancer hyperthermia treatment.